Form 4: Strata Medical Co-CEO Exercises Stock Options

Strata Critical Medical's Co-CEO and General Counsel, Melissa M. Tomkiel, exercised stock options to acquire 276,960 shares of Class A common stock at $0.18 per share.

Summary

• Melissa M. Tomkiel, who serves as Co-CEO and General Counsel for Strata Critical Medical, Inc. (SRTA), exercised stock options.
• The transaction took place on January 2, 2026.
• She acquired 276,960 shares of Class A common stock, with a par value of $0.0001 per share, at an exercise price of $0.18 per share.
• Following this exercise, her direct beneficial ownership of Class A common stock increased to 1,643,362 shares.
• The stock options exercised were originally exercisable from May 7, 2021, and had an expiration date of July 28, 2030.

Sentiment

Score: 7

Explanation: The exercise of stock options by a Co-CEO and General Counsel is generally viewed positively as it signifies insider confidence in the company's future prospects and stock value.

Positives

• Increased insider ownership by a key executive, signaling confidence in the company's future prospects.
• The exercise of options at $0.18 per share suggests the options were in-the-money, indicating potential value creation for the executive and alignment with shareholder interests.

Risks

• The value of the acquired shares is subject to market fluctuations and the company's future performance, which could impact the realized gain or loss for the executive.

Future Outlook

The exercise of stock options by a key executive typically indicates a positive outlook on the company's future performance and stock value, as the executive is increasing their direct equity stake.

Industry Context

Insider transactions, such as option exercises, are closely watched by investors as they can provide insights into management's confidence in the company's future. This is a standard practice for executive compensation and equity incentives across various industries.

Related Party Transactions

• The transaction involves an executive (Melissa M. Tomkiel) and the company (Strata Critical Medical, Inc.), which is a standard related party transaction for equity compensation and is reported as required by SEC regulations.

Stakeholder Impact

• Shareholders: Increased insider ownership may be perceived as a positive signal, potentially boosting investor confidence in the company's future.
• Employees: Reinforces the company's commitment to its executive compensation structure and aligns executive interests with long-term company performance.

Key Dates

Keywords

Strata Critical Medical, SRTA, insider transaction, stock options, Form 4, beneficial ownership, executive compensation, Melissa M. Tomkiel, common stock